Research for control: The onchocerciasis experience

Tropical Medicine and International Health

Volumn 9, Issue 2, 2004, Pages 243-254

  Remme, Jan H F ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Ivermectin; Modelling; Onchocerciasis; Research; Vector control

Indexed keywords

IVERMECTIN;

DISEASE CONTROL; DISEASE TREATMENT; DISEASE VECTOR; ONCHOCERCIASIS;

AFRICA; BLINDNESS; CLIMATE; CLINICAL FEATURE; COMMUNITY CARE; DISEASE SEVERITY; DRUG FATALITY; DRUG SAFETY; EPIDEMIOLOGICAL DATA; FILARIASIS; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; LOA LOA; MEDICAL RESEARCH; MODEL; NEUROLOGIC DISEASE; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE TRANSMISSION; PRURITUS; PUBLIC HEALTH; REVIEW; SIDE EFFECT; SIMULIUM; SKIN MANIFESTATION; SOCIAL PSYCHOLOGY; SUPERINFECTION; TREATMENT OUTCOME; TREATMENT PLANNING; VECTOR CONTROL;

AFRICA; ANIMALS; BIOMEDICAL RESEARCH; COST OF ILLNESS; DISEASE VECTORS; ENDEMIC DISEASES; FILARICIDES; HUMANS; IVERMECTIN; LOIASIS; MODELS, BIOLOGICAL; ONCHOCERCA; ONCHOCERCIASIS; PREVALENCE;

AFRICA;

LOA LOA; NEMATODA; ONCHOCERCA VOLVULUS;

EID: 1342322716     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2003.01192.x     Document Type: Review

References (70)

1. Abiose A, Jones BR, Cousens SN et al. (1993) Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis (see comments). Lancet 341, 130-134.
2. Amazigo U (1993) Onchocerciasis and women's reproductive health: indigenous and biomedical concepts. Tropical Doctor 23, 149-151.
3. Amazigo UV, Obono M, Dadzie KY et al. (2002) Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96 (Suppl. 1), S75-S92.
4. Benton B (1998) Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview. Annals of Tropical Medicine and Parasitology 92 (Suppl. 1), S33-S39.
5. Boakye DA, Back C, Fiasorgbor GK, Sib AP & Coulibaly Y (1998) Sibling species distributions of the Simulium damnosum complex in the west African Onchocerciasis Control Programme area during the decade 1984-93, following intensive larviciding since 1974. Medical and Veterinary Entomology 12, 345-358.
6. Borsboom GJ, Boatin BA, Nagelkerke NJ et al. (2003) Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria Journal 2, 8.
7. Boussinesq M, Chippaux JP, Ernould JC, Quillevere D & Prod'hon J (1995) Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon. American Journal of Veterinary Research 53, 63-67.
8. Boussinesq M, Gardon J, Kamgno J, Pion SD, Gardon-Wendel N & Chippaux JP (2001) Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon. Annals of Tropical Medicine and Parasitology 95, 495-507.
9. Brieger WR (2000) Implementation and Sustainability of Community-Directed Treatment of Onchocerciasis with Ivermectin. TDR/IDE/RP/CDTI/00.1. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva.
10. Brieger WR, Awedoba AK, Eneanya CI et al. (1998a) The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Tropical Medicine and International Health 3, 951-961.
11. Brieger WR, Oshiname FO & Ososanya OO (1998b) Stigma associated with onchocercal skin disease among those affected near the Ofiki and Oyan Rivers in western Nigeria. Social Science and Medicine 47, 841-852.
12. Burnham G (1995) Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi. American Journal of Tropical Medicine and Hygiene 52, 270-276.
13. Cupp EW, Ochoa JO, Collins RC et al. (1992) The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. American Journal of Tropical Medicine and Hygiene 47, 170-180.
14. Dadzie KY, Remme J, Rolland A & Thylefors B (1989) Ocular onchocerciasis and intensity of infection in the community. II. West African rainforest foci of the vector Simulium yahense. Tropical Medicine and Parasitology 40, 348-354.
15. Dadzie KY, Remme J, Baker RH, Rolland A & Thylefors B (1990) Ocular onchocerciasis and intensity of infection in the community. III. West African rainforest foci of the vector Simulium sanctipauli. Tropical Medicine and Parasitology 41, 376-382.
16. Dadzie KY, De Sole G & Remme J (1992) Ocular onchocerciasis and the intensity of infection in the community. IV. The degraded forest of Sierra Leone. Tropical Medicine and Parasitology 43, 75-79.
17. Dadzie Y, Neira M & Hopkins D (2003) Final report of the Conference on the eradicability of onchocerciasis. Filaria Journal 2, 2.
18. De Sole G, Remme J, Awadzi K et al. (1989) Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bulletin of the World Health Organization 67, 707-719.
19. De Sole G, Baker R, Dadzie KY et al. (1991) Onchocerciasis distribution and severity in five West African countries [published erratum appears in Bull World Health Organ 1992;70(2):286]. Bulletin of the World Health Organization 69, 689-698.
20. De Sole G, Accorsi S, Creusvaux H, Giese J, Keita FM & Remme J (1993) Distribution of onchocerciasis in selected river basins of four west African countries. Tropical Medicine and Parasitology 44, 159-164.
21. Duke BOL (1981) Geographical aspects of onchocerciasis. Annales de La Societe Belge de Medecine Tropicale (Proceedings Coll) 61, 179-185.
22. Edungbola LD, Alabi TO, Oni GA, Asaolu SO, Ogunbanjo BO & Parakoyi BD (1987) 'Leopard skin' as a rapid diagnostic index for estimating the endemicity of African onchocerciasis. International Journal of Epidemiology 16, 590-594.
23. Erttmann KD, Meredith SE, Greene BM & Unnasch TR (1990) Isolation and characterization of form specific DNA sequences of O. volvulus. Acta Leiden 59, 253-260.
24. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP & Boussinesq M (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection (see comments). Lancet 350, 18-22.
25. Gemade EI, Jiya JY, Nwoke BE et al. (1998) Human onchocerciasis: current assessment of the disease burden in Nigeria by rapid epidemiological mapping. Annals of Tropical Medicine and Parasitology 92 (Suppl. 1), S79-S83.
26. Gyapong M, Gyapong JO & Owusu-Banahene G (2001) Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Annals of Tropical Medicine and Parasitology 95, 77-86.
27. Hoerauf A, Walter RD, Remme H, Lazdins J & Fleischer B (2001) Call to consolidate achievements for onchocerciasis and lymphatic filariasis control. Trends in Parasitology 17, 566-567.
28. Homeida M, Braide E, Elhassan E et al. (2002) APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. Annals of Tropical Medicine and Parasitology 96, 93-104.
29. Hougard JM, Poudiougo P, Guillet P, Back C, Akpoboua LK & Quillevere D (1993) Criteria for the selection of larvicides by the Onchocerciasis Control Programme in west Africa. Annals of Tropical Medicine and Parasitology 87, 435-442.
30. Hougard JM, Alley ES, Yameogo L, Dadzie KY & Boatin BA (2001) Eliminating onchocerciasis after 14 years of vector control: a proved strategy. Journal of Infectious Diseases 184, 497-503.
31. Katabarwa M, Mutabazi D & Richards F (1999) The community-directed, ivermectin-treatment programme for onchocerciasis control in Uganda - an evaluative study (1993-1997) (In Process Citation). Annals of Tropical Medicine and Parasitology 93, 727-735.
32. Kipp W & Bamhuhiiga J (2002) Validity of nodule palpation in a Simulium neavei-transmitted onchocerciasis area in Uganda. American Journal of Tropical Medicine and Hygiene 67, 128-131.
33. Le Berre R (1968) Onchocerciasis vector control. A summary of the position in 1967 in parts of Upper Volta, Mali and the Ivory Coast. Médecine d'Afrique Noire 15, 71-72.
34. Mace J, Boussinesq M, Ngoumou P, Enyegue Oye J, Koeranga A & Godin C (1997) Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon. Annals of Tropical Medicine and Parasitology 91, 379-391.
35. Morel CM (2003) Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality? EMBO Reports 4, S35-S38.
36. Murdoch ME, Hay RJ, Mackenzie CD et al. (1993) A clinical classification and grading system of the cutaneous changes in onchocerciasis. British Journal of Dermatology 129, 260-269.
37. Murdoch ME, Asuzu MC, Hagan M et al. (2002) Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Annals of Tropical Medicine and Parasitology 96, 283-296.
38. Murray CJL & Lopez AD (1996) The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard School of Public Health, Boston, MA.
39. Ngoumou P, Walsh JF & Mace JM (1994) A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Annals of Tropical Medicine and Parasitology 88, 463-474.
40. Noma M, Nwoke BE, Nutall I et al. (2002) Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96 (Suppl. 1), 29-39.
41. Oladepo O, Brieger WR, Otusanya S, Kale OO, Offiong S & Titiloye M (1997) Farm land size and onchocerciasis status of peasant farmers in south-western Nigeria. Tropical Medicine and International Health 2, 334-340.
42. Ovuga EB, Okello DO, Ogwal Okeng JW, Orwotho N & Opoka RO (1995) Social and psychological aspects of onchocercal skin disease in Nebbi district Uganda. East African Medical Journal 72, 449-453.
43. Plaisier AP, van Oortmarssen GJ, Habbema JD, Remme J & Alley ES (1990) ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Computer Methods and Programs in Biomedicine 31, 43-56.
44. Plaisier AP, van Oortmarssen GJ, Remme J, Alley ES & Habbema JD (1991a) The risk and dynamics of onchocerciasis recrudes-cence after cessation of vector control. Bulletin of the World Health Organization 69, 169-178.
45. Plaisier AP, van Oortmarssen GJ, Remme J & Habbema JD (1991b) The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Tropica 48, 271-284.
46. Plaisier AP, Alley ES, van Oortmarssen GJ, Boatin BA & Habbema JD (1997) Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. Bulletin of the World Health Organization 75, 237-245.
47. Remme JHF (1995) The African Programme for Onchocerciasis Control: preparing to launch. Parasitology Today 11, 403-406.
48. Remme JHF (in press) Onchocerciasis. In: The Global Epidemiology of Infectious Diseases (eds CJL Murray & A Lopez) Harvard University Press, Cambridge.
49. Remme JHF & Zongo JB (1989) Demographic aspects of the epidemiology and control of onchocerciasis in West Africa. In: Demography and Vector-Borne Diseases (ed. MW Service) CRC Press, Boca Raton, pp. 367-386.
50. Remme J, Ba O, Dadzie KY & Karam M (1986) A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bulletin of the World Health Organization 64, 667-681.
51. Remme J, Baker RH, De Sole G et al. (1989a) A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus. Tropical Medicine and Parasitology 40, 367-374.
52. Remme J, Dadzie KY, Rolland A & Thylefors B (1989b) Ocular onchocerciasis and intensity of infection in the community. I. West African savanna. Tropical Medicine and Parasitology 40, 340-347.
53. Remme J, De Sole G, Dadzie KY et al. (1990) Large scale ivermectin distribution and its epidemiological consequences. Acta Leiden 59, 177-191.
54. Remme JHF, Alley ES & Plaisier AP (1995) Estimation and prediction in tropical disease control: the example of onchocerciasis. In: Epidemic Models: their Structure and Relation to Data (ed. D Mollison) Cambridge University Press, Cambridge, pp. 372-392.
55. Remme JH, Bias E, Chitsulo L et al. (2002) Strategic emphases for tropical diseases research: a TDR perspective. Trends in Parasitology 18, 421-426.
56. Roberts JMD, Neumann E, Gockel CW & Highton RB (1967) Onchocerciasis in Kenya 9, 11, and 18 years after elimination of the vector. Bulletin of the World Health Organization 37, 195-212.
57. Takougang I, Meremikwu M, Wandji S et al. (2002) Rapid assessment method for prevalence and intensity of Loa loa infection. Bulletin of the World Health Organization 80, 852-858.
58. Taylor HR, Pacque M, Munoz B & Greene BM (1990) Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science 250, 116-118.
59. Taylor HR, Duke BO & Munoz B (1992) The selection of communities for treatment of onchocerciasis with ivermectin. Tropical Medicine and Parasitology 43, 267-270.
60. TDR (1992) Methods for Community Diagnosis of Onchocerciasis to Guide Ivermectin Based Control in Africa. (TDR/TDE/ ONCHO/92.2) WHO, Geneva.
61. TDR (1996) Community-Directed Treatment with Ivermectin: Report of a Multi-country Study. (TDR/AFT/RP/96.1) WHO, Geneva.
62. Thomson MC, Obsomer V, Dunne M, Connor SJ & Molyneux DH (2000) Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa. Lancet 356, 1077-1078.
63. Vivas-Martinez S, Basanez MG, Botto C, Villegas L, Garcia M & Curtis CF (2000) Parasitological indicators of onchocerciasis relevant to ivermectin control programmes in the Amazonian focus of Southern Venezuela. Parasitology 121, 527-534.
64. Vlassoff C, Weiss M, Ovuga EB et al. (2000) Gender and the stigma of onchocercal skin disease in Africa. Social Science and Medicine 50, 1353-1368.
65. Walsh JF, Davies JB & Cliff B (1981) World Health Organization Onchocerciasis Control Programme in the Volta River Basin. In: Blackflies: the Future for Biological Methods in Integrated Control (ed. M Laird) Academic Press, London, pp. 85-103.
66. Whitworth JA & Gemade E (1999) Independent evaluation of onchocerciasis rapid assessment methods in Benue State, Nigeria. Tropical Medicine and International Health 4, 26-30.
67. WHO (1991) Strategies for Ivermectin Distribution Through Primary Health Care Systems. (WHO/PBL/91.24) WHO, Geneva.
68. WHO (1995) Onchocerciasis and its control. Report of a WHO expert committee on onchocerciasis control. World Health Organization Technical Report Series 852, 1-104.
69. World Bank (1996) African Programme for Onchocerciasis Control: Programme Document. Committee of Sponsoring Agencies, World Bank, Washington
70. Zimmerman PA, Dadzie KY, De Sole G, Remme J, Alley ES & Unnasch TR (1992) Onchocerca volvulus DNA probe classification correlates with epidemiologic patterns of blindness. Journal of Infectious Diseases 165, 964-968.